Acorah Software Products - Accounts Production 16.3.350 false true false true No description of principal activity 27 September 2023 30 September 2024 30 September 2024 15168020 Dr Mohammad Almasri iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 15168020 2023-09-26 15168020 2024-09-30 15168020 2023-09-27 2024-09-30 15168020 frs-bus:PrivateLimitedCompanyLtd 2023-09-27 2024-09-30 15168020 frs-bus:FilletedAccounts 2023-09-27 2024-09-30 15168020 frs-bus:Micro-entities 2023-09-27 2024-09-30 15168020 frs-bus:AuditExempt-NoAccountantsReport 2023-09-27 2024-09-30 15168020 frs-bus:Director1 2023-09-27 2024-09-30
Heathrow Pharma Ltd
Unaudited Financial Statements
For The Year Ended 30 September 2024
Balance Sheet
Registered number: 15168020
2024
£
Current assets 100
NET CURRENT ASSETS 100
TOTAL ASSETS LESS CURRENT LIABILITIES 100
NET ASSETS 100
CAPITAL AND RESERVES 100

Notes

1. General Information
Heathrow Pharma Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 15168020 . The registered office is C/O Abacus Pegasus Court, 27 Herschel Street, Slough, SL1 1PA.
2. Average Number of Employees
Average number of employees, including directors, during the year was: NIL
-
For the year ending 30 September 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Dr Mohammad Almasri
Director
27/06/2025